THE BIOAVAILABILITY OF ORAL AND PARENTERAL CHLORIMIPRAMINE (ANAFRANIL)

被引：40

作者：

EVANS, LEJ

BETT, JHN

COX, JR

DUBOIS, JP

VANHEES, T

机构：

[1] ROYAL BRISBANE HOSP,DEPT CARDIOL,BRISBANE,QLD 4029,AUSTRALIA

[2] CIBA GEIGY AG,DEPT RES,CH-4002 BASEL,SWITZERLAND

来源：

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY | 1980年 / 4卷 / 03期

关键词：

D O I：

10.1016/0364-7722(80)90050-8

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：293 / 302

页数：10

共 22 条

[1] AVAILABILITY OF ORALLY ADMINISTERED NORTRIPTYLINE [J].

ALEXANDERSON, B ;

BORGA, O ;

ALVAN, G .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1973, 5 (03) :181-185

[2] RELATIONSHIP BETWEEN PLASMA LEVEL AND THERAPEUTIC EFFECT OF NORTRIPTYLINE [J].

ASBERG, M ;

CRONHOLM, B ;

SJOQVIST, F ;

TUCK, D .

BRITISH MEDICAL JOURNAL, 1971, 3 (5770) :331-&

[3] CORRELATION OF SUBJECTIVE SIDE EFFECTS WITH PLASMA CONCENTRATIONS OF NORTRIPTYLINE [J].

ASBERG, M ;

CRONHOLM, B ;

TUCK, D ;

SJOQVIST, F .

BRITISH MEDICAL JOURNAL, 1970, 4 (5726) :18-&

[4]

BRAITHWA.RA, 1972, LANCET, V1, P1297

[5]

BURROWS GD, 1972, LANCET, V2, P619

[6] DEPRESSIVE REACTIONS IN COURSE OF CLOMIPRAMINE THERAPY USED IN TREATMENT OF OBSESSIONAL CONDITIONS [J].

CAPSTICK, N .

SCOTTISH MEDICAL JOURNAL, 1975, 20 :45-48

[7]

COLGAN A, 1975, SCOTT MED J S1, V20, P57

[8]

DIETERLE W, 1973, 21973 CIBA GEIG LTD

[9]

DUBOIS JP, 1976, CLIN CHEM, V22, P892

[10]

Faigle J.W., 1973, J INT MED RES, V1, P281, DOI [10.1177/030006057300100502, DOI 10.1177/030006057300100502]

← 1 2 3 →